NOV 08, 2018 11:15 AM PST

Is Daily Aspirin Safe For Heart Attack Prevention

WRITTEN BY: Abbie Arce

The benefits of aspirin use in patients with known cardiovascular disease (CVD) are well-established. A 2015 meta-analysis reviewed data gathered from 118,445 individuals from 11 trials. In these trials, low-dose aspirin was administered as a daily anticoagulant for primary CVD prevention. That is to say that low-dose aspirin prescription was intended in these trials to prevent cardiovascular events before they occurred.

Researchers found that aspirin reduced the risk of myocardial infarction by 22% and of death by 6%. These results sound encouraging, but a more in-depth look at the data will reveal the reduction in risk comes at a cost.  Despite the benefits, aspirin therapy came with a 59% increase in gastrointestinal tract bleeding and a 33% increased risk of hemorrhagic stroke. This risks associated with aspirin therapy back the question, is it worth it?

 

In the above video Dr. Stevenson, the chairman of the department of cardiovascular medicine at the Cleveland Clinic discusses some of the risks and for whom that risk is elevated.

Source: Cleveland Clinic

About the Author
  • Abbie is an AFAA certified personal trainer and fitness instructor with an interest in all things health-science. She has recently graduated with her BS in Applied Sport and Exercise Science from Barry University in Miami. Next, she intends to earn an MPH with a focus in Epidemiology.
You May Also Like
JUN 07, 2020
Microbiology
JUN 07, 2020
Infants Exposed to Antibiotics are at Greater Risk for Childhood Obesity
The human gut hosts a huge community of microbes, potentially even before birth, which helps us digest and absorb nutrie ...
JUN 08, 2020
Cancer
JUN 08, 2020
Using Soft Tissue Sarcoma's Immune Defense as a Biomarker
Programmed cell death protein 1 (PD-1) has been a big player in the treatment of both autoimmune disease and cancer. PD- ...
JUN 15, 2020
Drug Discovery & Development
JUN 15, 2020
New Antibiotic 'Irresistin' Defeats All Resistant Bacteria
Researchers from Princeton University have identified a compound capable of killing both Gram-positive and Gram-negative ...
JUN 18, 2020
Drug Discovery & Development
JUN 18, 2020
FDA Cancels Emergency Approval for Hydroxychloroquine
The US Food and Drug Administration (FDA) has decided to cancel emergency use authorization for Hydroxychloroquine and C ...
JUN 29, 2020
Cancer
JUN 29, 2020
Mass Spectrometry and How It Can Profile Cancer
Treatments for cancer usually revolve around targeting certain immune checkpoints in the cell. Protein cell death protei ...
JUL 06, 2020
Cancer
JUL 06, 2020
Staying Active Could Help Patients with Metastatic HER2+ Breast Cancer
Breast cancer is the most lethal cancer affecting women worldwide. While most are caught early thanks to the many diagno ...
Loading Comments...